AORT Stock Summary and Trading Ideas (Artivion | NYSE:AORT)

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

Artivion trades on the NYSE stock market under the symbol AORT.

As of November 7, 2024, AORT stock price declined to $28.98 with 308,743 million shares trading.

AORT has a beta of 1.32, meaning it tends to be more sensitive to market movements. AORT has a correlation of 0.14 to the broad based SPY ETF.

AORT has a market cap of $1.21 billion. This is considered a Small Cap stock.

Last quarter Artivion reported $98 million in Revenue and $.07 earnings per share. This beat revenue expectation by $359,000 and exceeded earnings estimates by $.13.

The top ETF exchange traded funds that AORT belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.

AORT has outperformed the market in the last year with a price return of +110.2% while the SPY ETF gained +37.9%. AORT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +15.2% and +8.9%, respectively, while the SPY returned +15.2% and +2.8%, respectively.

AORT support price is $28.87 and resistance is $30.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AORT shares will trade within this expected range on the day.